About: New Insights of Emerging SARS-CoV-2: Epidemiology, Etiology, Clinical Features, Clinical Treatment, and Prevention

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: New Insights of Emerging SARS-CoV-2: Epidemiology, Etiology, Clinical Features, Clinical Treatment, and Prevention Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
title	New Insights of Emerging SARS-CoV-2: Epidemiology, Etiology, Clinical Features, Clinical Treatment, and Prevention
Creator	Huang, Hong Li, Xiaokun Chen, Yu Li, Wenshu Zhang, Lifang Ding, Ning Hu, Jiafen Chen, Zhiyuan Guo, Gangqiang Pan, Kan Rao, Jianyu Shioda, Tatsuo Xing, Dong Xue, Xiangyang Yan, Kejing Ye, Lele
source	Medline; PMC
abstract	Since the first reports that the novel coronavirus was showing human-to-human transmission characteristics and asymptomatic cases, the number of patients with associated pneumonia has continued to rise and the epidemic has grown. It now threatens the health and lives of people across the world. The governments of many countries have attached great importance to the prevention of SARS-CoV-2, via research into the etiology and epidemiology of this newly emerged disease. Clinical signs, treatment, and prevention characteristics of the novel coronavirus pneumonia have been receiving attention worldwide, especially from medical personnel. However, owing to the different experimental methods, sample sizes, sample sources, and research perspectives of various studies, results have been inconsistent, or relate to an isolated aspect of the virus or the disease it causes. Currently, systematic summary data on the novel coronavirus are limited. This review combines experimental and clinical evidence into a systematic analysis and summary of the current progress of research into SARS-CoV-2, from multiple perspectives, with the aim of gaining a better overall understanding of the disease. Our report provides important information for current clinicians, for the prevention and treatment of COVID-19 pneumonia.
has issue date	2020-05-22(xsd:dateTime)
bibo:doi	10.3389/fcell.2020.00410
bibo:pmid	32574318
has license	cc-by
sha1sum (hex)	361c81d0ef9cde7b19c7d5a85c37f0c11ad2534a
schema:url	https://doi.org/10.3389/fcell.2020.00410
resource representing a document's title	New Insights of Emerging SARS-CoV-2: Epidemiology, Etiology, Clinical Features, Clinical Treatment, and Prevention
has PubMed Central identifier	PMC7256189
has PubMed identifier	32574318
schema:publication	Front Cell Dev Biol
resource representing a document's body	covid:361c81d0ef9cde7b19c7d5a85c37f0c11ad2534a#body_text
is schema:about of	named entity 'worldwide' named entity 'prevention' named entity 'virus' named entity 'characteristics' named entity 'rise' named entity 'relate' named entity 'systematic' named entity 'studies' named entity 'GOVERNMENTS' named entity 'DATA' named entity 'EXPERIMENTAL' named entity 'RISE' named entity 'PEOPLE' named entity 'CASES' named entity 'CLINICAL SIGNS' named entity 'Clinical' named entity 'progress' named entity 'continued' named entity 'health' named entity 'current' named entity 'SARS-CoV-2' named entity 'sample' named entity 'governments' named entity 'epidemic' named entity 'attached' named entity 'isolated' named entity 'SARS-CoV-2' named entity 'Since' named entity 'Emerging' named entity 'clinical evidence' named entity 'epidemiology' named entity 'virus' named entity 'SARS-CoV-2' named entity 'pneumonia' named entity 'sample sizes' named entity 'Epidemiology' named entity 'cell culture' named entity 'TMPRSS2' named entity 'clinical evidence' named entity 'SARSr-CoV' named entity 'virus' named entity 'passive immunotherapy' named entity 'bronchoalveolar lavage fluid' named entity 'ACE2' named entity 'SARS-CoV-2' named entity 'sequencing data' named entity 'semen' named entity 'underlying diseases' named entity 'lymphocyte' named entity 'SARS-CoV-2' named entity 'SARS-CoV' named entity 'endosomes' named entity 'Covid-19' named entity 'proinflammatory cytokines' named entity 'MERS' named entity 'COVID-19 Response Team' named entity 'mouse model' named entity 'monoclonal antibody' named entity 'epitopes' named entity 'high blood pressure' named entity 'transcription' named entity 'Spike protein' named entity 'vaccine' named entity 'esophagus' named entity 'lung tissue' named entity '2019-nCoV'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software